Session

25.03.2021     15:15–16:00

Title:
Poster session 2
Antivirals and resistance II
Type:
ePoster session

25.03.2021
15:15–16:00

Title:
Poster session 2
Antivirals and resistance II
Type:
ePoster session

15:15–15:20
PS 63 AntiViroGram - proteome-wide prediction of antiviral peptide precursors
Michał Burdukiewicz (Białystok/PL)
Talk time: 3 + 2 min

15:20–15:25
PS 64 "From plant to bench…to bedside?" – Broad-spectrum antiviral potency of natural and synthetic rocaglates
Christin Müller (Gießen/DE)
Talk time: 3 + 2 min

15:25–15:30
PS 65 SARS-CoV-2-reprogrammed metabolism limits autophagy and uncovers drug targets
Jackson Emanuel (Berlin/DE)
Talk time: 3 + 2 min

15:30–15:35
PS 66 Caspase 3/7 activity-based screening platform reveals Proscillaridin A as a potent inhibitor of SARS-CoV-2
Denisa Bojkova (Frankfurt am Main/DE)
Talk time: 3 + 2 min

15:35–15:40
PS 67 A surrogate model for Hepatitis D virus replication and drug evaluation
Bingqian Qu (Langen/DE)
Talk time: 3 + 2 min

15:40–15:45
PS 68 Non-receptor tyrosine kinase inhibitors modulate replication of influenza A/H1N1pdm09 and A/H3N2 viruses in human in vitro and ex vivo tissue systems
Robert Meineke (Hannover/DE)
Talk time: 3 + 2 min

15:45–15:50
PS 69 Targeted mutagenesis on PDGFRα-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration
Christian Sinzger (Ulm/DE)
Talk time: 3 + 2 min

15:50–15:55
PS 70 Antiviral effect of nanostructured zinc oxide tetrapods against alpha herpesviruses
Gerrit Andresen (Kiel/DE)
Talk time: 3 + 2 min

15:55–16:00
PS 71 Analysis of transmitted drug resistance and HIV-1 subtypes in newly diagnosed HIV-1 cases in Germany - results from the national molecular surveillance 2017-2019
Uwe Fiebig (Berlin/DE)
Talk time: 3 + 2 min